Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L. Matthews is active.

Publication


Featured researches published by L. Matthews.


The Breast | 2014

Low grade Ductal Carcinoma in situ (DCIS): How best to describe it?

Lesley Fallowfield; L. Matthews; Adele Francis; Valerie Jenkins; Daniel Rea

BACKGROUND In the absence of definitive data about the natural history of DCIS the appropriateness of describing DCIS as cancer is controversial. METHODS We conducted a survey amongst British Breast Group (BBG) members, to determine which descriptions of DCIS were deemed most accurate and appropriate. RESULTS 54/73 (74%) attendees completed the survey: A majority (34/54; 63%) said they would be comfortable using the description that explained DCIS as abnormal cells in the milk ducts that had not spread into other breast tissue and which did not need urgent treatment as if it was breast cancer and this description was overall the most preferred (24/54; 44%). CONCLUSIONS Little consensus exists regarding how best to explain low grade DCIS to patients.


Supportive Care in Cancer | 2018

Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study

Valerie Jenkins; V. Farewell; Shirley May; Susan Catt; L. Matthews; Valerie Shilling; J. Dickson; Richard Simcock; Lesley Fallowfield


Psycho-oncology | 2018

Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing

Lesley Fallowfield; L. Matthews; Shirley May; Valerie Jenkins; David Bloomfield


Clinical Oncology | 2018

EXTREQOL Identifies Ongoing Challenges in Maximising Quality of Survival in Men with Metastatic Castrate-resistant Prostate Cancer

Valerie Jenkins; Heather Payne; Malcolm David Mason; Shirley May; L. Matthews; Susan Catt


Annals of Oncology | 2018

1548PPatients’ and partners’ views of treatment and care provided for metastatic castrate resistant prostate cancer (mCRPC) in the UK

Susan Catt; L. Matthews; Heather Payne; Malcolm David Mason; Valerie Jenkins


Journal of Clinical Oncology | 2017

Do drugs that offer PFS or modest OS benefits improve quality of life in patients with advanced cancer

Lesley Fallowfield; Susan Catt; Shirley May; Valerie Shilling; L. Matthews; Valerie Jenkins


Annals of Oncology | 2017

1125PThe cost-effectiveness of EndoPredict to inform adjuvant chemotherapy decisions in early breast cancer

S. Hinde; C. Theriou; S. May; L. Matthews; A. Arbon; Lesley Fallowfield; D. Bloomfield


European Journal of Cancer | 2015

1715 Patient reported outcome measures for cancer caregivers: A systematic review

V. Shilling; L. Matthews; Valerie Jenkins; Lesley Fallowfield


European Journal of Cancer | 2015

1534 Patients' understanding about the therapeutic aims of novel drugs shown only to offer PFS benefit

Lesley Fallowfield; S. May; Susan Catt; V. Shilling; L. Matthews; Valerie Jenkins


European Journal of Cancer | 2015

1542 Gaps and inconsistencies found in information available for men with mCRPC

Valerie Jenkins; L. Matthews; Lesley Fallowfield

Collaboration


Dive into the L. Matthews's collaboration.

Top Co-Authors

Avatar

Valerie Jenkins

Brighton and Sussex Medical School

View shared research outputs
Top Co-Authors

Avatar

Lesley Fallowfield

Brighton and Sussex Medical School

View shared research outputs
Top Co-Authors

Avatar

Susan Catt

Brighton and Sussex Medical School

View shared research outputs
Top Co-Authors

Avatar

Shirley May

Brighton and Sussex Medical School

View shared research outputs
Top Co-Authors

Avatar

Adele Francis

University Hospitals Birmingham NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Heather Payne

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

Daniel Rea

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge